- Personal FinanceCompare Online BrokersTop StocksAlternative Investing
- CryptoGet StartedNFTs
Acorda Therapeutics Stock (NASDAQ:ACOR), Quotes and News Summary
Acorda Therapeutics Stock (NASDAQ: ACOR)
| Day Range0.32 - 0.36 | 52 Wk Range0.26 - 2.6 | Open / Close0.33 / 0.34 | Float / Outstanding24.2M / 24.3M |
| Vol / Avg.667.9K / 327.7K | Mkt Cap8.3M | P/E- | 50d Avg. Price0.4 |
| Div / Yield- | Payout Ratio- | Total Float24.2M | EPS-2.78 |
Earnings
see more| Q3 2022 | Est. | Actual | Surprise | ||||
|---|---|---|---|---|---|---|---|
| EPS | (EXPECTED)2022-11-08 | ||||||
| REV | |||||||
| Q2 2022 | Est. | Actual | Surprise | ||||
|---|---|---|---|---|---|---|---|
| EPS | -3.150 | ||||||
| REV | 36.970M | 31.051M | -5.919M |
Analyst Ratings
see more| Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
|---|
Acorda Therapeutics Questions & Answers
You can purchase shares of Acorda Therapeutics (NASDAQ: ACOR) through any online brokerage.
Other companies in Acorda Therapeutics’s space includes: Virios Therapeutics (NASDAQ:VIRI), Addex Therapeutics (NASDAQ:ADXN), Midatech Pharma (NASDAQ:MTP), PhaseBio Pharmaceuticals (NASDAQ:PHAS) and Ensysce Biosciences (NASDAQ:ENSC).
The latest price target for Acorda Therapeutics (NASDAQ: ACOR) was reported by HC Wainwright & Co. on Thursday, June 17, 2021. The analyst firm set a price target for 10.00 expecting ACOR to rise to within 12 months (a possible 2841.18% upside). 0 analyst firms have reported ratings in the last year.
The stock price for Acorda Therapeutics (NASDAQ: ACOR) is $0.34 last updated Today at October 4, 2022, 8:00 PM UTC.
There are no upcoming dividends for Acorda Therapeutics.
Acorda Therapeutics’s Q3 earnings are confirmed for Tuesday, November 8, 2022.
There is no upcoming split for Acorda Therapeutics.
Acorda Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.